BELLEROPHON THERAPEUTICS INC - COM NEW (BLPH)

CUSIP: 078771300

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / COM NEW
Total 13F shares
1,135,486
Share change
-94,899
Total reported value
$2,678,000
Price per share
$2.36
Number of holders
17
Value change
-$231,946
Number of buys
3
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 078771300?
CUSIP 078771300 identifies BLPH - BELLEROPHON THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BELLEROPHON THERAPEUTICS INC - COM NEW (BLPH) as of Q1 2022

As of 31 Mar 2022, BELLEROPHON THERAPEUTICS INC - COM NEW (BLPH) was held by 17 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,135,486 shares. The largest 10 holders included VANGUARD GROUP INC, WELLS FARGO & COMPANY/MN, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., Telemetry Investments, L.L.C., GEODE CAPITAL MANAGEMENT, LLC, JANE STREET GROUP, LLC, NORTHERN TRUST CORP, STATE STREET CORP, and Tudor Investment Corp Et Al. This page lists 17 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.